======= DECR2 ======= == Gene Information == * **Official Symbol**: DECR2 * **Official Name**: 2,4-dienoyl-CoA reductase 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=26063|26063]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NUI1|Q9NUI1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=DECR2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20DECR2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/615839|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Auxiliary enzyme of beta-oxidation. Participates in the degradation of unsaturated fatty enoyl-CoA esters having double bonds in both even- and odd-numbered positions in peroxisome. Catalyzes the NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3-enoyl-CoA. Has activity towards short and medium chain 2,4-dienoyl-CoAs, but also towards 2,4,7,10,13,16,19- docosaheptaenoyl-CoA, suggesting that it does not constitute a rate limiting step in the peroxisomal degradation of docosahexaenoic acid. |adh short| |KR| |2,4-dienoyl-CoA reductase (NADPH) activity| |trans-2-enoyl-CoA reductase (NADPH) activity| |fatty acid beta-oxidation using acyl-CoA oxidase| |unsaturated fatty acid biosynthetic process| |fatty acid beta-oxidation| |peroxisomal membrane| |protein localization to peroxisome| |protein targeting to peroxisome| |establishment of protein localization to peroxisome| |peroxisomal transport| |fatty acid oxidation| |lipid oxidation| |peroxisome organization| |fatty acid catabolic process| |unsaturated fatty acid metabolic process| |monocarboxylic acid catabolic process| |fatty acid biosynthetic process| |monocarboxylic acid biosynthetic process| |cellular lipid catabolic process| |lipid modification| |organic acid catabolic process| |carboxylic acid catabolic process| |lipid catabolic process| |carboxylic acid biosynthetic process| |organic acid biosynthetic process| |fatty acid metabolic process| |protein targeting| |establishment of protein localization to organelle| |small molecule catabolic process| |monocarboxylic acid metabolic process| |lipid biosynthetic process| |small molecule biosynthetic process| |protein localization to organelle| |carboxylic acid metabolic process| |cellular lipid metabolic process| |oxidation-reduction process| |intracellular protein transport| |oxoacid metabolic process| |organic acid metabolic process| |lipid metabolic process| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| |establishment of localization in cell| |nitrogen compound transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|-1.9| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6467 * **Expression level (log2 read counts)**: 5.67 {{:chemogenomics:nalm6 dist.png?nolink |}}